Amgen Inc (NAS:AMGN)
$ 308.45 -1.7 (-0.55%) Market Cap: 165.46 Bil Enterprise Value: 220.69 Bil PE Ratio: 44.06 PB Ratio: 32.95 GF Score: 89/100

Amgen Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 10:10PM GMT
Release Date Price: $198.88 (-2.26%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Outstanding. Listen, guys, pleasure to have Amgen management join us to -- and a great first day at our conference. We have -- we were scheduled to have Arvind and Rob from the global development side, and I just learned that Peter is joining us as well. So thank you to all of you for being here.

Maybe I'll turn it over to you, Peter, just to kick things off, and we'll jump right into it.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

How are you doing, Umer? It's great to be here. It's nice to hear you and Eric and Mike. We appreciate the invitation as always. So thank you. And I'd just like to maybe share a few remarks on behalf of all of us at Amgen.

We feel like the company is well positioned for attractive long-term growth. Our 3 main drivers are volume-driven growth of our innovative brands and our biosimilar portfolio. We feel great about that. Secondly, some successful near-term launches: LUMAKRAS, as we all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot